Pharmacodynamic evaluation of the etonogestrel contraceptive implant initiated midcycle with and without ulipristal acetate: An exploratory study

To estimate the incidence of ovulation suppression within five days of etonogestrel 68 mg implant insertion in the presence of a dominant follicle with and without same-day ulipristal acetate. This single site non-masked, exploratory randomized trial recruited people age 18–35 years with regular men...

Full description

Saved in:

Bibliographic Details
Published in:	Contraception (Stoneham) Vol. 132; p. 110370
Main Authors:	Gawron, Lori M., Kaiser, Jennifer E., Gero, Alexandra, Sanders, Jessica N., Johnstone, Erica B., Turok, David K.
Format:	Journal Article
Language:	English
Published:	United States Elsevier Inc 01-04-2024
Subjects:	Adolescent Adult Contraception, Postcoital - methods Contraceptive Agents, Female - pharmacology Desogestrel Emergency contraception Etonogestrel implant Female Humans Norpregnadienes Ovulation Pharmacodynamics Ulipristal acetate Young Adult Pharmacodynamics Etonogestrel implant Ovulation Emergency contraception Ulipristal acetate
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!